Abstract
Chemokine receptors are G protein-coupled receptors that contain seven trans-membrane domains. CXCR4 and CCR5 as major co-receptors for HIV-1 entry into host cells are implicated in cancer and inflammation. They have been attractive targets for the pharmaceutical industry basing on their roles in HIV disease. Homology modeling, molecular docking, molecular dynamics, Molecular Mechanics/Generalized Born Surface Area and many other computational methods are applied to illustrate the structure, function and binding site of GPCR. Moreover, the high resolution crystal structures of CXCR4 and CCR5 have provided extremely valuable structural information and receptor activation mechanisms, enable structure-based drug discovery for the treatment of HIV-1 infection. We also describe the recent progress about the small molecule antagonists of CXCR4 and CCR5 and the interaction between GPCR and their ligands predicted by molecular docking and molecular dynamics methods. Future research questions and further investigations are outlined to highlight some researches that may be relevant to the advancement of therapies targeting the important receptor related with HIV.
Keywords: CCR5, computational methods, crystal structure, CXCR4, HIV, small molecular antagonists.
Current Pharmaceutical Biotechnology
Title:Progress in Studies of Structure, Mechanism and Antagonists Interaction of GPCR Co-Receptors for HIV
Volume: 15 Issue: 10
Author(s): Bing Zhong, Yunmei Zhen, Guangrong Qin, Huaiyu Yang, Hualiang Jiang, Guanghui Chen and Kunqian Yu
Affiliation:
Keywords: CCR5, computational methods, crystal structure, CXCR4, HIV, small molecular antagonists.
Abstract: Chemokine receptors are G protein-coupled receptors that contain seven trans-membrane domains. CXCR4 and CCR5 as major co-receptors for HIV-1 entry into host cells are implicated in cancer and inflammation. They have been attractive targets for the pharmaceutical industry basing on their roles in HIV disease. Homology modeling, molecular docking, molecular dynamics, Molecular Mechanics/Generalized Born Surface Area and many other computational methods are applied to illustrate the structure, function and binding site of GPCR. Moreover, the high resolution crystal structures of CXCR4 and CCR5 have provided extremely valuable structural information and receptor activation mechanisms, enable structure-based drug discovery for the treatment of HIV-1 infection. We also describe the recent progress about the small molecule antagonists of CXCR4 and CCR5 and the interaction between GPCR and their ligands predicted by molecular docking and molecular dynamics methods. Future research questions and further investigations are outlined to highlight some researches that may be relevant to the advancement of therapies targeting the important receptor related with HIV.
Export Options
About this article
Cite this article as:
Zhong Bing, Zhen Yunmei, Qin Guangrong, Yang Huaiyu, Jiang Hualiang, Chen Guanghui and Yu Kunqian, Progress in Studies of Structure, Mechanism and Antagonists Interaction of GPCR Co-Receptors for HIV, Current Pharmaceutical Biotechnology 2014; 15 (10) . https://dx.doi.org/10.2174/1389201015666141031120836
DOI https://dx.doi.org/10.2174/1389201015666141031120836 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Exosomes and the Emerging Field of Exosome-Based Gene Therapy
Current Gene Therapy Non-steroidal Anti-Inflammatory Drugs and Melanoma
Current Pharmaceutical Design The HCMV Chemokine Receptor US28 is a Potential Target in Vascular Disease
Current Drug Targets - Infectious Disorders Progress of Biological Agents on Psoriatic Arthritis
Current Pharmaceutical Biotechnology Bioactive Compounds in Some Culinary Aromatic Herbs and Their Effects on Human Health
Mini-Reviews in Medicinal Chemistry Lessons from Alzheimer's Disease (AD) Clinical Trials: Instead of “A-Drug”, AD-D prevention to Avert AD
Current Alzheimer Research Cyclooxygenase-2 Biology
Current Pharmaceutical Design Circulating Endothelial Cells: Markers and Mediators of Vascular Damage
Current Stem Cell Research & Therapy Why are People with “Poor Lung Function” At Increased Atherothrombotic Risk?A Critical Review with Potential Therapeutic Indications
Current Vascular Pharmacology Oxidative Stress and Psychological Disorders
Current Neuropharmacology Blockade of Chemokine-Mediated Tissue Injury in Lupus Nephritis
Endocrine, Metabolic & Immune Disorders - Drug Targets Vascular Effects of Ambient Pollutant Particles and Metals
Current Vascular Pharmacology The Adverse Effects of Smoking on Health Outcomes in Bipolar Disorder: A Review and Synthesis of Biological Mechanisms
Current Molecular Medicine The Nervous System as a Critical Regulator of Immune Responses Underlying Allergy
Current Pharmaceutical Design Mitochondria Sentencing About Cellular Life and Death: A Matter of Oxidative Stress
Current Pharmaceutical Design Leptin and Inflammation
Current Immunology Reviews (Discontinued) Drug Targets for Obesity and Depression: From Serotonin to Leptin
Current Drug Targets Preeclampsia: A Couples Disease with Maternal and Fetal Manifestations
Current Pharmaceutical Design Editorial (Thematic Issue: Epigenetic Regulation and Human Diseases)
Current Pharmaceutical Design Nanoparticles as Alternative Strategies for Drug Delivery to the Alzheimer Brain: Electron Microscopy Ultrastructural Analysis
CNS & Neurological Disorders - Drug Targets